AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal

AstraZeneca is already considering offloading MedImmune's vaccines business, just days after it paid $15.2bn (£7.6bn, E11.2bn) for the US biotech.
The Business